The province is celebrating the success of a program that treats people at risk of an HIV infection, both prior to exposure, or to those who may already have been exposed to the disease. Adrian Dix, Minister of Health says the province is seeing a consistent decline in new cases of HIV since no-cost coverage […]
BC leading the way when it comes to HIV treatment Read More »
People throughout B.C. are benefiting from expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), as strong uptake for the publicly funded drug continues to grow. “The expansion of coverage for PrEP and PEP keeps B.C. at the forefront of fighting the spread of HIV and AIDS,” said Adrian Dix, Minister of Health.
Celebrating six months of success preventing new HIV infections throughout B.C. Read More »
PEOPLE throughout B.C. are benefiting from expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), as strong uptake for the publicly funded drug continues to grow. “The expansion of coverage for PrEP and PEP keeps B.C. at the forefront of fighting the spread of HIV and AIDS,” said Adrian Dix, Minister of Health.
Celebrating six months of success preventing new HIV infections throughout B.C. Read More »
Since the start of 2018, more than 2,000 people have been prescribed a potentially life-saving drug to prevent new HIV infections in B.C. That’s according to B.C. Health Minister Adrian Dix, who says the province continues to lead the way in the global fight against the disease. The cutting-edge strategies are called PrEP and PEP,
VANCOUVER-The Ministry of Health is reporting strong success six months into a program expanding coverage of HIV prevention medications. On Jan. 1, the province began covering the costs of preexposure prophylaxis treatment, also known as PrEP, for patients deemed at-risk. On Tuesday, Minister Adrian Dix announced that so far 1,944 people have received free PrEP,
Six months in, province celebrates uptake for free HIV prevention drugs Read More »
VANCOUVER (NEWS 1130) – More than 2,000 people in this province have benefited from the expanded coverage of drugs that can prevent HIV infection. Health Minister Adrian Dix called BC’s treatment “world-leading” at an announcement this morning. “There are an estimated 7,271 British Columbians living with HIV today. Preventing new infections and giving people the
People throughout B.C. are benefiting from expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), as strong uptake for the publicly funded drug continues to grow.
Celebrating six months of success preventing new HIV infections throughout B.C. Read More »
Strategies to reduce new HIV infections span multifaceted efforts, including safe-sex counseling, voluntary medical male circumcision, treatment as prevention, and pre- (PrEP) and postexposure prophylaxis. PrEP entails the use of antiretroviral (ARV) drugs prophylactically by HIV-negative individuals at risk of infection to thwart acquisition of the virus. In 2012, the US Food and Drug Administration
Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis Read More »
Pre-exposure prophylaxis, commonly known as PrEP, is a “game-changer” when it comes to preventing HIV infections, doctors say. But some new studies are suggesting that people who take it use condoms less often – increasing their risk of contracting other sexually-transmitted infections. PrEP is a combination of two drugs, initially used to treat HIV. But
‘Game-changer’ HIV prevention drug could be leading to lower condom use: studies Read More »
When celebrated author and alternative medicine advocate Deepak Chopra visited Palm Springs in early February, he had an epiphany. Invited to be a featured speaker in the Palm Springs Speaks lecture series, he visited Desert AIDS Project before his event that evening. While touring the campus Chopra realized he was seeing the real-life manifestation of
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
